Showing 5221-5230 of 21466 results for "".
- Solta Medical’s Thermage Receives China Trademark Recognitionhttps://reachmd.com/news/solta-medicals-thermage-receives-china-trademark-recognition/2487286/Solta Medical, Bausch Health Companies Inc.’s aesthetic business, announced that Thermage has received AAA Well-Known Trademark Certification from the China Trademark Association. The certification is reserved for select brands in mainland China and recognizes Thermage’s brand reputation,
- Continuous Superficial Parasternal Blockade After Sternotomyhttps://reachmd.com/news/continuous-superficial-parasternal-blockade-after-sternotomy/2487268/Key Takeaways Continuous blockade was not associated with lower sternal pain on standardized coughing at 24 hours than the single-injection blockade control strategy. No between-group differences were seen in secondary outcomes, including sternal pain
- Blood Flow Restriction After ACL Reconstruction Shows No Added Benefithttps://reachmd.com/news/blood-flow-restriction-after-acl-reconstruction-shows-no-added-benefit/2487269/Key Takeaways No statistically significant between-group differences were seen for the primary or secondary outcomes. Both groups improved over time in subjective pain, maximum strength, active and passive range of motion, and IKDC scores. Blo
- Adjunctive Prednisolone Does Not Lower Coronary Lesions in Kawasaki Diseasehttps://reachmd.com/news/adjunctive-prednisolone-does-not-lower-coronary-lesions-in-kawasaki-disease/2487275/Key Takeaways Adjunctive prednisolone was not associated with a lower 1-month incidence of coronary-artery lesions. Prednisolone was associated with lower rescue-therapy use, shorter fever duration, and greater CRP reduction, while coronary z-score dec
- Cabotegravir-Rilpivirine Lowers Regimen Failure in LATITUDE Trialhttps://reachmd.com/news/cabotegravir-rilpivirine-lowers-regimen-failure-in-latitude-trial/2487267/Key Takeaways Monthly injections were associated with lower regimen failure than standard oral ART during the randomized phase. Participants first received adherence support, conditional incentives, and oral ART before only those with viral suppression
- Magnetic Seizure Therapy Matches ECT Remission in Depression Trialhttps://reachmd.com/news/magnetic-seizure-therapy-matches-ect-remission-in-depression-trial/2487274/Key Takeaways Magnetic seizure therapy met the prespecified non-inferiority criterion for remission, although remission was numerically higher with right unilateral ultra-brief pulse-width electroconvulsive therapy. Autobiographical memory worsening wa
- Familial Melanoma Genes Associated With Expanded Spectrum of Malignancieshttps://reachmd.com/news/familial-melanoma-genes-associated-with-expanded-spectrum-of-malignancies/2487300/A new study published in JAMA Dermatology suggests pathogenic variants (PVs) in familial melanoma susceptibility genes are present in up to 0.9% of the general population. Investigators for the
- Rubedo Reports Early Clinical Activity for GPX4 Modulator RLS-1496 in Actinic Keratosishttps://reachmd.com/news/rubedo-reports-early-clinical-activity-for-gpx4-modulator-rls-1496-in-actinic-keratosis/2487263/Rubedo Life Sciences announced preliminary findings from a Phase 1b/2a trial evaluating topical RLS-1496 1% cream in adults with actinic keratosis (AK), reporting reductions in lesion counts alongside favorable tolerability data. The interim findings were presented at the RBC Capital Markets Glob
- Case Series Evaluates Anatomy-Based Thread Lifting for Nasolabial Fold Rejuvenationhttps://reachmd.com/news/case-series-evaluates-anatomy-based-thread-lifting-for-nasolabial-fold-rejuvenation/2487262/A personalized, anatomy-guided thread lifting strategy using multiple vector patterns demonstrated favorable aesthetic outcomes for nasolabial fold (NLF) correction in a small retrospective case series published in JPRAS Open. In the study, investigators evaluated 22 patients trea
- Ecopipam Maintains Tic Suppression In Tourette Syndrome Trialhttps://reachmd.com/news/ecopipam-tic-suppression-tourette/2487243/Key Takeaways Relapse during withdrawal was less frequent with continued ecopipam in pediatric participants and showed a similar pattern in the overall randomized population. Exploratory tic and global impression measures generally favored continued ec